Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | MET proto-oncogene, receptor tyrosine kinase | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | References |
Homo sapiens | macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0454 | 0.2767 | 0.465 |
Loa Loa (eye worm) | thymidylate synthase | 0.0955 | 0.595 | 1 |
Onchocerca volvulus | 0.0032 | 0.008 | 0.013 | |
Trypanosoma cruzi | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | 0.0151 | 0.0841 | 0.1414 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0955 | 0.595 | 1 |
Echinococcus granulosus | uridine 5' monophosphate synthase | 0.0151 | 0.0841 | 0.141 |
Loa Loa (eye worm) | orotate phosphoribosyltransferase | 0.0151 | 0.0841 | 0.1414 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.008 | 0.0135 |
Loa Loa (eye worm) | sema domain-containing protein | 0.002 | 0.0003 | 0.0005 |
Schistosoma mansoni | orotidine 5'-phosphate decarboxylase | 0.0151 | 0.0841 | 0.141 |
Brugia malayi | thymidylate synthase | 0.0955 | 0.595 | 1 |
Echinococcus granulosus | thymidylate synthase | 0.0955 | 0.595 | 1 |
Brugia malayi | hypothetical protein | 0.002 | 0.0003 | 0.0005 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0955 | 0.595 | 1 |
Schistosoma mansoni | plexin | 0.0032 | 0.008 | 0.013 |
Brugia malayi | Sema domain containing protein | 0.002 | 0.0003 | 0.0005 |
Plasmodium vivax | orotidine 5'-phosphate decarboxylase, putative | 0.0137 | 0.0752 | 0.0995 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0003 | 0.0005 |
Onchocerca volvulus | 0.0955 | 0.595 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0003 | 0.0005 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0955 | 0.595 | 0.5877 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0955 | 0.595 | 0.5914 |
Brugia malayi | hypothetical protein | 0.002 | 0.0003 | 0.0005 |
Brugia malayi | Cytochrome P450 family protein | 0.0032 | 0.0079 | 0.0133 |
Echinococcus multilocularis | thymidylate synthase | 0.0955 | 0.595 | 1 |
Leishmania major | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative,OMPDCase-OPRTase, putative | 0.0151 | 0.0841 | 0.1414 |
Mycobacterium ulcerans | orotidine 5'-phosphate decarboxylase | 0.0137 | 0.0752 | 0.0752 |
Onchocerca volvulus | 0.0568 | 0.3489 | 0.5862 | |
Echinococcus multilocularis | uridine 5' monophosphate synthase | 0.0151 | 0.0841 | 0.141 |
Trypanosoma cruzi | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | 0.0151 | 0.0841 | 0.1414 |
Brugia malayi | hypothetical protein | 0.0454 | 0.2767 | 0.465 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0454 | 0.2767 | 0.5 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0955 | 0.595 | 1 |
Trypanosoma cruzi | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | 0.0137 | 0.0752 | 0.1264 |
Brugia malayi | plexin A | 0.004 | 0.0135 | 0.0227 |
Toxoplasma gondii | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase | 0.0137 | 0.0752 | 0.0995 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0955 | 0.595 | 1 |
Mycobacterium leprae | Probable orotidine 5'-phosphate decarboxylase PyrF (OMP decarboxylase) (OMPDCase) (OMPdecase) | 0.0137 | 0.0752 | 0.0585 |
Loa Loa (eye worm) | plexin A | 0.004 | 0.0135 | 0.0227 |
Trypanosoma brucei | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | 0.0151 | 0.0841 | 0.1414 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0032 | 0.0079 | 0.0133 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0003 | 0.0005 |
Brugia malayi | Sema domain containing protein | 0.002 | 0.0003 | 0.0005 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0955 | 0.595 | 1 |
Plasmodium falciparum | orotidine 5'-phosphate decarboxylase | 0.0137 | 0.0752 | 0.0995 |
Wolbachia endosymbiont of Brugia malayi | orotidine-5'-phosphate decarboxylase | 0.0672 | 0.4153 | 1 |
Brugia malayi | orotate phosphoribosyltransferase family protein | 0.0151 | 0.0841 | 0.1414 |
Brugia malayi | Plexin repeat family protein | 0.0032 | 0.008 | 0.0135 |
Echinococcus multilocularis | plexin a4 | 0.004 | 0.0135 | 0.0222 |
Echinococcus granulosus | plexin a4 | 0.004 | 0.0135 | 0.0222 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0454 | 0.2767 | 0.2703 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0003 | 0.0005 |
Mycobacterium ulcerans | orotate phosphoribosyltransferase | 0.0047 | 0.0177 | 0.0177 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0003 | 0.0005 |
Mycobacterium ulcerans | thymidylate synthase | 0.0955 | 0.595 | 0.595 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0955 | 0.595 | 1 |
Mycobacterium tuberculosis | Probable orotate phosphoribosyltransferase PyrE (OPRT) (oprtase) | 0.0047 | 0.0177 | 0.009 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0955 | 0.595 | 1 |
Loa Loa (eye worm) | sema domain-containing protein | 0.002 | 0.0003 | 0.0005 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0003 | 0.0005 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | Toxicity in CD1 nu/nu mouse xenografted with human GLT16 cells assessed as change in body weight relative to control | ChEMBL. | 23379595 | |
IC50 (binding) | = 1 nM | Inhibition of c-MET (unknown origin)-catalyzed N-biotinylated EQEDEPEGDYFEWLECONH2 phosphorylation by TR-FRET assay | ChEMBL. | 23379595 |
IC50 (binding) | = 7 nM | Inhibition of RON (unknown origin) by TR-FRET assay | ChEMBL. | 23379595 |
IC50 (binding) | < 12 nM | Inhibition of c-MET (unknown origin) in presence of 10 % FBS | ChEMBL. | 23379595 |
IC50 (binding) | = 29 nM | Inhibition of HGF-stimulated c-MET (unknown origin) autophosphorylation at tyrosine 1349 expressed in human GTL16 cells after 2 hrs by Western blotting analysis | ChEMBL. | 23379595 |
IC50 (binding) | = 582 nM | Inhibition of c-MET (unknown origin) expressed in human GTL16 cells assessed as inhibition of cell proliferation | ChEMBL. | 23379595 |
IC50 (binding) | > 10000 nM | Inhibition of c-MET activation (unknown origin) expressed in human HCT116 cells | ChEMBL. | 23379595 |
IC50 (ADMET) | = 11580 nM | Inhibition of CYP3A4 in human liver microsomes using testosterone as substrate by LC-MS-MS analysis | ChEMBL. | 23379595 |
IC50 (ADMET) | = 14730 nM | Inhibition of CYP2C9 (unknown origin) | ChEMBL. | 23379595 |
IC50 (ADMET) | = 46170 nM | Inhibition of CYP2D6 (unknown origin) | ChEMBL. | 23379595 |
IC50 (functional) | = 1.7 uM | In vivo inhibition of c-MET phosphorylation at tyrosine Y1349 in human GTL16 cells xenografted in po dosed mouse after 8 hrs by Western blotting analysis | ChEMBL. | 23379595 |
Inhibition (functional) | In vivo inhibition of c-MET phosphorylation at tyrosine Y1349 in human GTL16 cells xenografted in mouse at 100 mg/kg, po after 1 hr by Western blotting analysis | ChEMBL. | 23379595 | |
Inhibition (ADMET) | = 31 % | Inhibition of CYP3A4 in human liver microsomes using testosterone as substrate at 10 uM by LC-MS-MS analysis relative to control | ChEMBL. | 23379595 |
Inhibition (binding) | = 60 % | Inhibition of MER (unknown origin) relative to control | ChEMBL. | 23379595 |
Inhibition (binding) | = 60 % | Inhibition of FLT4 (unknown origin) relative to control | ChEMBL. | 23379595 |
Inhibition (binding) | = 60 % | Inhibition of FGFR3 (unknown origin) relative to control | ChEMBL. | 23379595 |
Inhibition (binding) | = 60 % | Inhibition of FES (unknown origin) relative to control | ChEMBL. | 23379595 |
Inhibition (binding) | > 90 % | Inhibition of RON (unknown origin) at 1 uM by TR-FRET assay relative to control | ChEMBL. | 23379595 |
Inhibition (binding) | > 90 % | Inhibition of c-MET (unknown origin)-catalyzed N-biotinylated EQEDEPEGDYFEWLECONH2 phosphorylation at 1 uM by TR-FRET assay relative to control | ChEMBL. | 23379595 |
Kd (binding) | = 3.2 nM | Binding affinity to phosphorylated c-MET kinase domain (unknown origin) | ChEMBL. | 23379595 |
Kd (binding) | = 10.4 nM | Binding affinity to unphosphorylated c-MET kinase domain (unknown origin) | ChEMBL. | 23379595 |
TDI (ADMET) | = 16 % | Time dependent inhibition of CYP3A4 in human liver microsomes using testosterone as substrate at 10 uM preincubated for 30 mins by LC-MS-MS analysis relative to control | ChEMBL. | 23379595 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 23379595 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.